GlassScriptPhysician profile
Krystyn Riddle
NPI 1619242781
$780.40
in general payments reported to CMS, 2019-2025
14 companies · $84.83 in 2025
The $84.83 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.63 · 2022: $89.98 · 2023: $433 · 2024: $128 · 2025: $84.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $342.44 | 2023-2024 | Bracanalysis Cdx, Myrisk |
| Merck Sharp & Dohme LLC | $99.97 | 2022-2025 | Keytruda, Lynparza |
| Baxter Healthcare | $55.67 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $50.02 | 2023 | Exparel |
| Ethicon US, LLC | $44.82 | 2025 | Surgicel Nu-Knit, Vistaseal, Ethicon |
| Organogenesis INC. | $41.88 | 2024-2025 | Affinity |
| Mimedx Group, INC. | $30.71 | 2024 | |
| Genentech USA, INC. | $24.39 | 2023 | Tecentriq |
| Vertex Pharmaceuticals Incorporated | $19.88 | 2024 | |
| Baudax Bio INC. | $18.88 | 2021 | |
| Medtronic, INC. | $14.34 | 2023 | Ligasure |
| Innocoll Pharmaceuticals Limited | $13.10 | 2021 | |
| Olympus America INC. | $12.65 | 2021 | |
| Bioventus LLC | $11.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystyn Riddle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.